March Biosciences Funding & Investors
March Biosciences is a clinical-stage cell therapy company that focuses on developing CAR-T cell strategies to address hematological cancers.
march.bioTotal Amount Raised: $18,200,000
March Biosciences Funding Rounds
Grant
$13,400,000
Grant Investors
Cancer Prevention & Research Institute of TexasSeed
$4,800,000
Seed Investors
Cancer Focus Fund
Funding info provided by Diffbot.